There's no official definition, which tells you something about how young this practice is
However, with the shortage officially declared over, the FDA has set deadlines for these entities to cease compounding semaglutide injectionsApril 22, 2025, for 503A compounding pharmacies and May 22, 2025, for 503B outsourcing facilities
In other words, WADA expects athletes to simply take as correct the estimated concentration of a Section 4 Substance as reported by the laboratory for their A sample, notwithstanding that the very purpose of B sample analyses is to provide athletes with the opportunity to check the laboratorys results/workings/methods
Recently, the injectable has been cropping up in the news again but for different reasons
doi: 10.3389/fcimb.2017.00012 84 HoldenV
Mild gastrointestinal symptoms (nausea, reduced appetite, occasional constipation) are the most frequently reported and usually resolve within the first few weeks as the body adjusts